Gene · 5244
Papers3,400
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
401 to 420 of 3,400
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Primary Recurrent Common Bile Duct Stones: Timing of Surgical Intervention. | J Clin Med Res | 2022 | 36578366 | PubTator, text mining | PubMed |
| Bile acids as inflammatory mediators and modulators of intestinal permeability. | Front Immunol | 2022 | 36569849 | PubTator, text mining | PubMed |
| Case series of progressive familial intrahepatic cholestasis type 3: Characterization of variants in ABCB4 in China. | Front Med (Lausanne) | 2022 | 36569137 | PubTator, text mining | PubMed |
| Acting on the CFTR Membrane-Spanning Domains Interface Rescues Some Misfolded Mutants. | Int J Mol Sci | 2022 | 36555865 | PubTator, text mining | PubMed |
| Pharmacophore-Oriented Identification of Potential Leads as CCR5 Inhibitors to Block HIV Cellular Entry. | Int J Mol Sci | 2022 | 36555761 | PubTator, text mining | PubMed |
| Internal Ileal Diversion as Treatment for Progressive Familial Intrahepatic Cholestasis Type 1-Associated Graft Inflammation and Steatosis after Liver Transplantation. | Children (Basel) | 2022 | 36553407 | PubTator, text mining | PubMed |
| Clinical and genetic characterization of pediatric patients with progressive familial intrahepatic cholestasis type 3 (PFIC3): identification of 14 novel ABCB4 variants and review of the literatures. | Orphanet J Rare Dis | 2022 | 36550572 | PubTator, text mining | PubMed |
| Applications of In Silico Models to Predict Drug-Induced Liver Injury. | Toxics | 2022 | 36548621 | PubTator, text mining | PubMed |
| Pharmacogenetics of chemotherapy treatment response and -toxicities in patients with osteosarcoma: a systematic review. | BMC Cancer | 2022 | 36536332 | PubTator, text mining | PubMed |
| Role of bile acids in overweight and obese children and adolescents. | Front Endocrinol (Lausanne) | 2022 | 36531484 | PubTator, text mining | PubMed |
| Farnesoid X receptor antagonizes macrophage-dependent licensing of effector T lymphocytes and progression of sclerosing cholangitis. | Sci Transl Med | 2022 | 36516265 | PubTator, text mining | PubMed |
| Complex impacts of gallstone disease on metabolic syndrome and nonalcoholic fatty liver disease. | Front Endocrinol (Lausanne) | 2022 | 36506064 | PubTator, text mining | PubMed |
| Role of intestinal flora in primary sclerosing cholangitis and its potential therapeutic value. | World J Gastroenterol | 2022 | 36504550 | PubTator, text mining | PubMed |
| Recent Advances in the Digestive, Metabolic and Therapeutic Effects of Farnesoid X Receptor and Fibroblast Growth Factor 19: From Cholesterol to Bile Acid Signaling. | Nutrients | 2022 | 36500979 | PubTator, text mining | PubMed |
| TRPML2 Mucolipin Channels Drive the Response of Glioma Stem Cells to Temozolomide and Affect the Overall Survival in Glioblastoma Patients. | Int J Mol Sci | 2022 | 36499683 | PubTator, text mining | PubMed |
| Allelic frequencies of mutants of the Plasmodium falciparum, quinoline and folate metabolizing genes in the west region of Cameroon. | Heliyon | 2022 | 36451747 | PubTator, text mining | PubMed |
| Current medical education improves OSA-related knowledge but not confidence in residents: An underappreciated public health risk. | Front Psychiatry | 2022 | 36440416 | PubTator, text mining | PubMed |
| Synthesis and Iodine Adsorption Properties of Organometallic Copolymers with Propeller-Shaped Fe(II) Clathrochelates Bridged by Different Diaryl Thioether and Their Oxidized Sulfone Derivatives. | Polymers (Basel) | 2022 | 36432945 | PubTator, text mining | PubMed |
| Nutraceutical Approaches to Dyslipidaemia: The Main Formulative Issues Preventing Efficacy. | Nutrients | 2022 | 36432457 | PubTator, text mining | PubMed |
| Skin Manifestations in Patients with Selective Immunoglobulin E Deficiency. | J Clin Med | 2022 | 36431272 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5244/papers?page=21